Discover why uniQure N.V. (NASDAQ:QURE) is one of the top 24 stocks skyrocketing, with a remarkable 258% jump in Q4 2024. The gene therapy leader shows strong growth potential, backed by revenue increase and favorable Wall Street outlook.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing